Narcotics Analgesics Market Size & Share, by Type (Non-Opioids, Opioids); Application (Pain Management, Cough Treatment, Diarrhea); Administration Route (Oral, Intravenous, Rectal, Transdermal, Topical) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4203
  • Published Date: Feb 22, 2023
  • Report Format: PDF, PPT

Companies Dominating the Narcotics Analgesics Landscape

    • Pfizer Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Teva Pharmaceutical Industries Ltd.
    • AbbVie Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Sanofi S.A.
    • Abbott Laboratories
    • Janssen Global Services, LLC
    • Novartis AG
    • Bayer AG
    • GlaxoSmithKline plc

Browse Key Market Insights with Data Illustration:


In The News

  •  Johnson & Johnson Services, Inc. announced a settlement agreement with the State of New York and its subdivisions, resolving their opioid-related claims against the Company. The settlement will provide about USD 263 million in funding for New York and its subdivisions to address opioid-related issues and as reimbursement for attorney fees and costs.

  • AbbVie Inc. in association with Neurocrine Biosciences, Inc. announced the release of first and only gonadotropin-releasing hormone ORILISSA that has been approved by the U.S Food and Drug Administration.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4203
  • Published Date: Feb 22, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increased research for cancer treatment drugs and rising consumption of different types of drugs are the major factors driving the growth of the narcotics analgesics market.

The market is anticipated to attain a CAGR of ~5% over the forecast period, i.e., 2023-2035.

Shortage of analgesic medication and addiction to narcotics drugs are estimated to hamper the market growth.

The market in North America is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Pfizer Inc, Teva Pharmaceutical Industries Ltd., AbbVie Inc, Sun Pharmaceutical Industries Ltd., Sanofi, Abbott, Janssen Pharmaceuticals, LLC, Novartis AG, Bayer AG, GlaxoSmithKline plc, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, application, administration route, and by region.

The oral segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying